A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia - Concepedia

Concepedia

Publication | Closed Access

A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia

35

Citations

19

References

2006

Year

Gonzalo Gomez-Abuin, Eric Winquist, Walter M. Stadler, Pamela Degendorfer, Malcolm J. Moore

Investigational New Drugs

Metastatic Urothelial CancerUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicinePrincess Margaret HospitalPhase Ii StudyMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1